Product Program year 2025 Source: CMS Open Payments

Rejoyn

Device Psychiatry

PDI 00857335005121

Open in the dashboard

General payments

$259,177

1,144 payments

Research payments

$0

0 payments

Through program year 2025, $259,177 in general payments and $0 in research payments were reported against Rejoyn (Psychiatry).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $127,723 784
2024 General $131,454 360

Breakdown

Who paid General payments · program years 2024–2025
  1. Otsuka Pharmaceutical Development & Commercialization, Inc. $259,177 1,144 payments
Top recipients General payments · program year 2025
  1. Sagar Parikh Psychiatry · Ann Arbor, MI $19,300 15% · 2 payments
  2. Gustavo Alva Psychiatry · Orange, CA $15,057 12% · 8 payments
  3. Arwen Podesta Psychiatry · New Orleans, LA $10,229 8% · 4 payments
  4. Robert McCarron Psychiatry · Sacramento, CA $8,940 7% · 8 payments
  5. Veronica Ridpath Psychiatry · Florence, SC $5,825 5% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Psychiatry Psychiatry & Neurology $87,873 70% · 171 practitioners
  2. Nurse Practitioner, Psychiatric/Mental Health Nurse Practitioner $16,411 13% · 175 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $7,452 6% · 44 practitioners
  4. Physician Assistant $5,344 4% · 57 practitioners
  5. Family Medicine $4,790 4% · 24 practitioners

The top 5 of 43 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $30,285 24% · 51 recipients
  2. Michigan $19,440 15% · 8 recipients
  3. Texas $11,692 9% · 47 recipients
  4. Florida $10,474 8% · 122 recipients
  5. Louisiana $10,229 8% · 1 recipient

The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,144 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record